MedTrace Logo

Comparison of Core Stability and Hip Strengthening Protocols in Sacroiliac Joint Dysfunction

NCT07716215 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-07-21

No results posted yet for this study

Summary

The aim of this research is to compare the effects of core stability exercises and hip strengthening exercises on pain, posture, balance, proprioception, and functional status in patients with sacroiliac joint dysfunction. A randomized controlled trial will be conducted at Benazir Bhutto Hospital. The sample size will be 22 participants. The subjects will be divided into two groups, 11 subjects in the core stability exercise group and 11 subjects in the hip strengthening exercise group. The study duration will be 6 months. The sampling technique applied will be non-probability purposive sampling. Only 25-55 years individuals with unilateral sacroiliac joint dysfunction for more than 3 months and NPRS score ≥5 will be included. Tools used in the study are Numeric Pain Rating Scale (NPRS), Oswestry Disability Index (ODI), Pelvic Inclinometer, Flexicurve Ruler, Gait and Balance App, and Joint Repositioning Error test. Data will be analyzed through SPSS version 25.

Conditions

  • Sacroiliac Joint Dysfunction

Interventions

OTHER

Core Stabilization

Each session will begin with hot pack application over the sacroiliac region for 10 minutes followed by the exercise protocol and cool-down stretching. Treatment will be provided 3 sessions per week for 4 weeks, with each session lasting approximately 40-45 minutes.

OTHER

Hip Strengthening Exercises

Exercises will be performed with resistance at approximately 75-80% repetition maximum for 2-3 sets of 8-12 repetitions. Each session will start with 10 minutes of hot pack application over the sacroiliac region followed by strengthening exercises and cool-down stretching including hamstring and piriformis stretches. Treatment will be provided 3 sessions per week for 4 weeks, with each session lasting approximately 40-45 minutes.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Muhammad Affan Iqbal, PhD* · Riphah International University

  • Saba Naz, MSPT* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-10-30
Completion
2026-11-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07716215 on ClinicalTrials.gov